Oncologic outcomes of neoadjuvant chemotherapy and lymph node dissection with partial cystectomy for muscle-invasive bladder cancer.
Ryan M AntarVincent E XuChristian M FaragJack LuceroArthur DrouaudVinaik SundaresanOlivia F GordonSarah AzariMichael WynneArmine K SmithMichael J WhalenPublished in: Translational andrology and urology (2024)
Despite guideline recommendations, the utilization of NAC and PLND with PC remains insufficient. Our analysis underscores the significant OS benefit of these recommended treatments as part of MIBC care. Importantly, we highlight a gradual increase in NAC and PLND receipt in recent years, centered largely at academic facilities. Notably, gender disparities exist in PLND receipt, emphasizing the need for further investigation.
Keyphrases
- neoadjuvant chemotherapy
- sentinel lymph node
- locally advanced
- lymph node
- rectal cancer
- muscle invasive bladder cancer
- transcription factor
- robot assisted
- radical prostatectomy
- healthcare
- affordable care act
- palliative care
- prostate cancer
- mental health
- quality improvement
- genome wide analysis
- early stage
- type diabetes
- health insurance
- chronic pain